Results 161 to 170 of about 6,114,826 (359)

NCCN Trends [PDF]

Journal of the National Comprehensive Cancer Network, 2011
openaire   +2 more sources

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Spatially refined satellite gravimetry captures human signatures in global terrestrial water storage trends. [PDF]

Proc Natl Acad Sci U S A
O'Neill MM, Rodell M, Loomis BD.
europepmc   +1 more source

Australian Education Technologies Trends 2018

, 2018
The Australian Educational Technologies Trends (AETT) report provides an overview to assist teachers, school leaders, academics and industry, in understanding and planning for the use of digital technologies in Australian schools over the next five years
Jones, M, Madsen, S, Harris, N, Sercombe, P, Speranza, A, Zagami, Jason, Flintoff, K, Vernon, K, Canning, C, Hogan, A, Joy, T, Finch, R, Shires, R, Redmond, P, Sleeman, T, et al.   +15 more
core  

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Public Search Behavior and Tuberculosis Cases in Indonesia 2019-2023: An Infodemiology Study Using Google Trends . [PDF]

F1000Res
Rahayu SR, Merzistya ANA, Pranindita SK, Saharani A, Ardiyani VN, Muanifah EZ, Cahyati WH, Maharani C, Fandani DA, Widiastuti E, Daniswari A, Azizan NA.   +11 more
europepmc   +1 more source

Industry 4.0: state of the art and future trends

International Journal of Production Research, 2018
Lida Xu, E. Xu, Ling Li
semanticscholar   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

A global decline in atmospheric dust during the 21st century. [PDF]

Sci Adv
Gupta AK, Kok JF, Amiridis V, Gkikas A, Rizos K, Proestakis E, Logothetis SA, Marinou E, García-Pando CP.   +8 more
europepmc   +1 more source

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

JAMA Oncology, 2017
A. Dasari, Chan Shen, D. Halperin, Bo Zhao, Shouhao Zhou, Ying Xu, T. Shih, James C. Yao   +7 more
semanticscholar   +1 more source